Sinphar Pharmaceutical Sep revenue falls to NT$254.4M
Sinphar Pharmaceutical Co. Ltd. reported September revenue of NT$254,433,000 versus NT$328,509,000 in the prior year, based on Taiwan Stock Exchange data. Jan–Sep revenue was NT$2,545,929,000 versus NT$2,493,845,000.